NRSN
NASDAQ · Biotechnology
Neurosense Therapeutics Ltd
$0.94
+0.07 (+8.03%)
Open$0.87
Previous Close$0.87
Day High$0.96
Day Low$0.86
52W High$36.15
52W Low$25.52
Volume—
Avg Volume541.4K
Market Cap27.91M
P/E Ratio—
EPS$0.19
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+3,648.3% upside
Current
$0.94
$0.94
Target
$35.23
$35.23
$27.84
$35.23 avg
$57.14
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.58M | 1.62M | 1.28M |
| Net Income | 134.3K | 163.7K | 131.8K |
| Profit Margin | 8.5% | 10.1% | 10.3% |
| EBITDA | 233.3K | 224.5K | 177.5K |
| Free Cash Flow | 149.0K | 201.8K | 175.9K |
| Rev Growth | +15.5% | +19.0% | +13.7% |
| Debt/Equity | 0.19 | 0.18 | 0.19 |
Dividend
Dividend Yield1.75%
Annual Dividend$0.59
Payout Ratio95.0%
Frequencyquarterly
Ex-DividendApr 15, 2026
Pay DateMay 6, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |